The global Oral Drug Delivery market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Oral Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Oral Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Oral Drug Delivery include AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc. and Novartis AG, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Oral Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Oral Drug Delivery, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Oral Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Oral Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc. and Novartis AG, etc.
By Company
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc
Segment by Type
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System
Segment by Application
Hospitals
Clinics
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oral Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Drug Delivery sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Oral Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Oral Drug Delivery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Diffusion Controlled Release System
1.2.3 Dissolution Controlled Release System
1.2.4 Ion Exchange Resins Controlled Release
1.2.5 Hydro-dynamically Balanced Drug Delivery System
1.2.6 Osmotically Controlled Release System
1.2.7 Dissolution & Diffusion Controlled Release System
1.3 Market by Application
1.3.1 Global Oral Drug Delivery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oral Drug Delivery Sales Estimates and Forecasts 2018-2029
2.2 Global Oral Drug Delivery Revenue by Region
2.2.1 Global Oral Drug Delivery Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Oral Drug Delivery Revenue by Region (2018-2023)
2.2.3 Global Oral Drug Delivery Revenue by Region (2024-2029)
2.2.4 Global Oral Drug Delivery Revenue Market Share by Region (2018-2029)
2.3 Global Oral Drug Delivery Sales Estimates and Forecasts 2018-2029
2.4 Global Oral Drug Delivery Sales by Region
2.4.1 Global Oral Drug Delivery Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Oral Drug Delivery Sales by Region (2018-2023)
2.4.3 Global Oral Drug Delivery Sales by Region (2024-2029)
2.4.4 Global Oral Drug Delivery Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oral Drug Delivery Sales by Manufacturers
3.1.1 Global Oral Drug Delivery Sales by Manufacturers (2018-2023)
3.1.2 Global Oral Drug Delivery Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Drug Delivery in 2022
3.2 Global Oral Drug Delivery Revenue by Manufacturers
3.2.1 Global Oral Drug Delivery Revenue by Manufacturers (2018-2023)
3.2.2 Global Oral Drug Delivery Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Oral Drug Delivery Revenue in 2022
3.3 Global Key Players of Oral Drug Delivery, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Oral Drug Delivery Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Drug Delivery, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Drug Delivery, Product Offered and Application
3.8 Global Key Manufacturers of Oral Drug Delivery, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Drug Delivery Sales by Type
4.1.1 Global Oral Drug Delivery Historical Sales by Type (2018-2023)
4.1.2 Global Oral Drug Delivery Forecasted Sales by Type (2024-2029)
4.1.3 Global Oral Drug Delivery Sales Market Share by Type (2018-2029)
4.2 Global Oral Drug Delivery Revenue by Type
4.2.1 Global Oral Drug Delivery Historical Revenue by Type (2018-2023)
4.2.2 Global Oral Drug Delivery Forecasted Revenue by Type (2024-2029)
4.2.3 Global Oral Drug Delivery Revenue Market Share by Type (2018-2029)
4.3 Global Oral Drug Delivery Price by Type
4.3.1 Global Oral Drug Delivery Price by Type (2018-2023)
4.3.2 Global Oral Drug Delivery Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Oral Drug Delivery Sales by Application
5.1.1 Global Oral Drug Delivery Historical Sales by Application (2018-2023)
5.1.2 Global Oral Drug Delivery Forecasted Sales by Application (2024-2029)
5.1.3 Global Oral Drug Delivery Sales Market Share by Application (2018-2029)
5.2 Global Oral Drug Delivery Revenue by Application
5.2.1 Global Oral Drug Delivery Historical Revenue by Application (2018-2023)
5.2.2 Global Oral Drug Delivery Forecasted Revenue by Application (2024-2029)
5.2.3 Global Oral Drug Delivery Revenue Market Share by Application (2018-2029)
5.3 Global Oral Drug Delivery Price by Application
5.3.1 Global Oral Drug Delivery Price by Application (2018-2023)
5.3.2 Global Oral Drug Delivery Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Oral Drug Delivery Market Size by Type
6.1.1 US & Canada Oral Drug Delivery Sales by Type (2018-2029)
6.1.2 US & Canada Oral Drug Delivery Revenue by Type (2018-2029)
6.2 US & Canada Oral Drug Delivery Market Size by Application
6.2.1 US & Canada Oral Drug Delivery Sales by Application (2018-2029)
6.2.2 US & Canada Oral Drug Delivery Revenue by Application (2018-2029)
6.3 US & Canada Oral Drug Delivery Market Size by Country
6.3.1 US & Canada Oral Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Oral Drug Delivery Sales by Country (2018-2029)
6.3.3 US & Canada Oral Drug Delivery Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oral Drug Delivery Market Size by Type
7.1.1 Europe Oral Drug Delivery Sales by Type (2018-2029)
7.1.2 Europe Oral Drug Delivery Revenue by Type (2018-2029)
7.2 Europe Oral Drug Delivery Market Size by Application
7.2.1 Europe Oral Drug Delivery Sales by Application (2018-2029)
7.2.2 Europe Oral Drug Delivery Revenue by Application (2018-2029)
7.3 Europe Oral Drug Delivery Market Size by Country
7.3.1 Europe Oral Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Oral Drug Delivery Sales by Country (2018-2029)
7.3.3 Europe Oral Drug Delivery Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oral Drug Delivery Market Size
8.1.1 China Oral Drug Delivery Sales (2018-2029)
8.1.2 China Oral Drug Delivery Revenue (2018-2029)
8.2 China Oral Drug Delivery Market Size by Application
8.2.1 China Oral Drug Delivery Sales by Application (2018-2029)
8.2.2 China Oral Drug Delivery Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Drug Delivery Market Size by Type
9.1.1 Asia Oral Drug Delivery Sales by Type (2018-2029)
9.1.2 Asia Oral Drug Delivery Revenue by Type (2018-2029)
9.2 Asia Oral Drug Delivery Market Size by Application
9.2.1 Asia Oral Drug Delivery Sales by Application (2018-2029)
9.2.2 Asia Oral Drug Delivery Revenue by Application (2018-2029)
9.3 Asia Oral Drug Delivery Sales by Region
9.3.1 Asia Oral Drug Delivery Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Oral Drug Delivery Revenue by Region (2018-2029)
9.3.3 Asia Oral Drug Delivery Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Drug Delivery Market Size by Type
10.1.1 Middle East, Africa and Latin America Oral Drug Delivery Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Oral Drug Delivery Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oral Drug Delivery Market Size by Application
10.2.1 Middle East, Africa and Latin America Oral Drug Delivery Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Oral Drug Delivery Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oral Drug Delivery Sales by Country
10.3.1 Middle East, Africa and Latin America Oral Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Oral Drug Delivery Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Oral Drug Delivery Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca Plc.
11.1.1 AstraZeneca Plc. Company Information
11.1.2 AstraZeneca Plc. Overview
11.1.3 AstraZeneca Plc. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 AstraZeneca Plc. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Plc. Recent Developments
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Information
11.2.2 Mylan N.V. Overview
11.2.3 Mylan N.V. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Mylan N.V. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan N.V. Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sanofi Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 F. Hoffman-La-Roche Ltd.
11.4.1 F. Hoffman-La-Roche Ltd. Company Information
11.4.2 F. Hoffman-La-Roche Ltd. Overview
11.4.3 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffman-La-Roche Ltd. Recent Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Information
11.5.2 Bristol-Myers Squibb Company Overview
11.5.3 Bristol-Myers Squibb Company Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Bristol-Myers Squibb Company Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Company Recent Developments
11.6 Sun Pharmaceuticals Industries Ltd
11.6.1 Sun Pharmaceuticals Industries Ltd Company Information
11.6.2 Sun Pharmaceuticals Industries Ltd Overview
11.6.3 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Abbott Laboratories Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Company Information
11.8.2 Merck & Co. Inc. Overview
11.8.3 Merck & Co. Inc. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Merck & Co. Inc. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck & Co. Inc. Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Overview
11.9.3 Novartis AG Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Novartis AG Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis AG Recent Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Information
11.10.2 Pfizer Inc. Overview
11.10.3 Pfizer Inc. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Pfizer Inc. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. Recent Developments
11.11 Vectura Group plc.
11.11.1 Vectura Group plc. Company Information
11.11.2 Vectura Group plc. Overview
11.11.3 Vectura Group plc. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Vectura Group plc. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Vectura Group plc. Recent Developments
11.12 GlaxoSmithKline plc.
11.12.1 GlaxoSmithKline plc. Company Information
11.12.2 GlaxoSmithKline plc. Overview
11.12.3 GlaxoSmithKline plc. Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 GlaxoSmithKline plc. Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GlaxoSmithKline plc. Recent Developments
11.13 Johnson & Johnson Services, Inc
11.13.1 Johnson & Johnson Services, Inc Company Information
11.13.2 Johnson & Johnson Services, Inc Overview
11.13.3 Johnson & Johnson Services, Inc Oral Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Johnson & Johnson Services, Inc Oral Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Johnson & Johnson Services, Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Drug Delivery Industry Chain Analysis
12.2 Oral Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Drug Delivery Production Mode & Process
12.4 Oral Drug Delivery Sales and Marketing
12.4.1 Oral Drug Delivery Sales Channels
12.4.2 Oral Drug Delivery Distributors
12.5 Oral Drug Delivery Customers
13 Market Dynamics
13.1 Oral Drug Delivery Industry Trends
13.2 Oral Drug Delivery Market Drivers
13.3 Oral Drug Delivery Market Challenges
13.4 Oral Drug Delivery Market Restraints
14 Key Findings in The Global Oral Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc
听
听
*If Applicable.